Recent Quarter Total Invested
$10.53 M
Recent Quarter Institutional Ownership Percentage
27.15%
Total Invested of Last Quarter
$17.42 M
Ownership Percentage of Last Quarter
27.92%
Cue Biopharma, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLEICHROEDER LP | 11/13/2024 | 5.00 M | $3.78 M | 74.63% | 9.75% |
SLATE PATH CAPITAL LP | 11/14/2024 | 2.40 M | $1.82 M | 0.00% | 4.69% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 570,975 | $432,342 | 100.00% | 1.11% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 508,827 | $385,370 | 3.32% | 0.99% |
ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC | 11/12/2024 | 478,500 | $362,320 | 0.00% | 0.93% |
SIGMA PLANNING CORP | 11/04/2024 | 401,325 | $303,883 | 50.86% | 0.78% |
GOOD LIFE ADVISORS, LLC | 10/16/2024 | 400,000 | $302,880 | 23.08% | 0.78% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 358,974 | $271,815 | -27.33% | 0.70% |
GSA CAPITAL PARTNERS LLP | 11/05/2024 | 291,663 | $221,000 | 5.08% | 0.57% |
ADVISORY RESEARCH INC | 11/14/2024 | 257,225 | $194,771 | 0.00% | 0.50% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 239,202 | $181,077 | -1.39% | 0.47% |
STIFEL FINANCIAL CORP | 11/14/2024 | 194,222 | $147,067 | 0.12% | 0.38% |
STATE STREET CORP | 11/14/2024 | 177,053 | $134,065 | 0.00% | 0.35% |
HIGHTOWER ADVISORS, LLC | 11/14/2024 | 83,284 | $64,000 | 0.00% | 0.16% |
UBS GROUP AG | 11/14/2024 | 74,175 | $56,150 | 25.69% | 0.14% |
MORGAN STANLEY | 11/14/2024 | 33,692 | $25,512 | -72.16% | 0.07% |
XTX TOPCO LTD | 11/14/2024 | 27,665 | $20,948 | 100.00% | 0.05% |
QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 24,672 | $18,682 | -69.25% | 0.05% |
POINT72 ASIA (SINGAPORE) PTE. LTD. | 11/14/2024 | 24,098 | $18,247 | -54.56% | 0.05% |
WELLS FARGO & COMPANY/MN | 11/13/2024 | 20,077 | $15,202 | -2.93% | 0.04% |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 10/28/2024 | 20,000 | $15,000 | -9.91% | 0.04% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 18,563 | $14,056 | -93.03% | 0.04% |
LPL FINANCIAL LLC | 11/08/2024 | 17,925 | $13,573 | 0.00% | 0.04% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 14,575 | $10,896 | -93.19% | 0.03% |
CITADEL ADVISORS LLC | 11/14/2024 | 14,400 | $10,904 | 12.50% | 0.03% |
SEACREST WEALTH MANAGEMENT, LLC | 10/16/2024 | 13,000 | $9,844 | 0.00% | 0.03% |
BEACON POINTE ADVISORS, LLC | 11/14/2024 | 10,000 | $7,572 | 0.00% | 0.02% |
LEGACY CAPITAL GROUP CALIFORNIA, INC. | 10/23/2024 | 10,000 | $7,572 | 0.00% | 0.02% |
11/14/2024 | 9,000 | $6,814 | 100.00% | 0.02% | |
BARCLAYS PLC | 11/19/2024 | 6,029 | $5,000 | -67.05% | 0.01% |
GLEASON GROUP, INC. | 10/15/2024 | 6,000 | $4,543 | 0.00% | 0.01% |
SIMPLEX TRADING, LLC | 11/08/2024 | 4,056 | $3,000 | 100.00% | 0.01% |
NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 11/12/2024 | 3,000 | $2,272 | 0.00% | 0.01% |
CITADEL ADVISORS LLC | 11/14/2024 | 2,600 | $1,969 | -76.58% | 0.01% |
NEWEDGE ADVISORS, LLC | 11/14/2024 | 2,550 | $1,931 | 0.00% | 0.01% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/12/2024 | 2,500 | $1,893 | 400.00% | 0.00% |
LARSON FINANCIAL GROUP LLC | 11/12/2024 | 1,400 | $1,060 | 100.00% | 0.00% |
JPMORGAN CHASE & CO | 11/08/2024 | 904 | $685 | 0.00% | 0.00% |
HARBOUR INVESTMENTS, INC. | 11/04/2024 | 439 | $332 | 0.00% | 0.00% |
ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 380 | $288 | 0.00% | 0.00% |
SUNBELT SECURITIES, INC. | 11/18/2024 | 237 | $179 | 0.00% | 0.00% |
SRS CAPITAL ADVISORS, INC. | 11/06/2024 | 215 | $163 | 0.00% | 0.00% |
ARMSTRONG ADVISORY GROUP, INC | 10/11/2024 | 120 | $91 | 0.00% | 0.00% |
POINT72 (DIFC) LTD | 11/14/2024 | 58 | $44 | -99.50% | 0.00% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
COMERICA BANK | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
DOHENY ASSET MANAGEMENT /CA | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
PALOMA PARTNERS MANAGEMENT CO | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
RHUMBLINE ADVISERS | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Cue Biopharma, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CUE shares?
During the previous two years, 81 institutional investors and hedge funds held shares of Cue Biopharma, Inc.. The most heavily invested institutionals were:
Bleichroeder LP: 5 M
Slate Path Capital LP: 2.4 M
BlackRock Funding, Inc. /DE: 570,975
GEODE CAPITAL MANAGEMENT, LLC: 508,827
Robertson Stephens Wealth Management, LLC: 478,500
Sigma Planning Corp: 401,325
-
What percentage of Cue Biopharma, Inc. stock is owned by institutional investors?
27.15% of Cue Biopharma, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at CUE ?
Institutional investors have bought a total of 12.62 M shares in the last 24 months. This purchase volume represents approximately $13.38 M in transactions.